Allergan plc (AGN) said it has received an Acceptable for Filing letter from the U.S. Food and Drug Administration for its Abbreviated New Drug Application or ANDA seeking approval to market Rifaximin Tablets, 550 mg.
from RTT - Biotech http://ift.tt/1nbdCHX
via IFTTT
No comments:
Post a Comment